Tyra Biosciences Inc.

NASDAQ: TYRA · Real-Time Price · USD
10.73
0.03 (0.28%)
At close: Aug 15, 2025, 3:59 PM
10.73
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tyra Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
519K 353K 296K 140K
Gross Profit
n/a -353K -296K -140K
Operating Income
-104.18M -79.94M -58.93M -26.29M
Interest Income
n/a 10.85M 3.65M 13K
Pretax Income
-86.48M -69.13M -55.33M -26.29M
Net Income
-86.48M -69.13M -51.72M -26.14M
Selling & General & Admin
24.1M 17.43M 15.92M 5.65M
Research & Development
80.08M 62.16M 43.01M 20.64M
Other Expenses
n/a n/a -50K -19K
Operating Expenses
104.18M 79.94M 58.93M 26.29M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 79.94M 58.93M 26.29M
Income Tax Expense
n/a n/a -3.6M -153K
Shares Outstanding (Basic)
57.22M 42.7M 41.88M 41.44M
Shares Outstanding (Diluted)
57.22M 42.7M 41.88M 41.44M
EPS (Basic)
-1.51 -1.62 -1.23 -0.63
EPS (Diluted)
-1.51 -1.62 -1.23 -0.63
EBITDA
-85.96M -79.59M -58.63M -26.15M
EBIT
-86.48M -79.94M -58.93M -26.29M
Depreciation & Amortization
519K 353K 296K 140K